NCT00598572 Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage Status COMPLETED Phase PHASE1
NCT00586196 Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period Status COMPLETED Phase PHASE2
NCT00585078 Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00580333 Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00577382 SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma Status COMPLETED Phase PHASE2
NCT00576680 RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00556205 Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma Status WITHDRAWN Phase PHASE2
NCT00556049 Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00554515 The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00545792 Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers Status COMPLETED Phase PHASE2
NCT00543907 Outcomes of a Deep Inferior Epigastric Perforator Flap Program Status COMPLETED Phase N/A
NCT00543114 Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL Status TERMINATED Phase PHASE1
NCT00542451 Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT00538161 Effect of Low Tidal Volume Ventilation in Improving Oxygenation and Thus Reducing Acute Lung Injury in the Cardiac Surgical Patient Status COMPLETED Phase NA
NCT00533923 Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders Status COMPLETED Phase PHASE2